Advertisement
Advertisement
Pfizer
TOPIC
 / company

Pfizer

Pfizer
Pfizer
The latest news, analysis and opinion on Pfizer. In-depth analysis, industry insights and expert opinion.
Chairman / President
Albert Bourla
CEO / Managing Director
Albert Bourla
CFO / Finance Director
Dave Denton
Industry
Pharmaceuticals
Website
pfizer.com
Headquarters address
235 East 42nd Street, New York, NY 10017, United States
Stock Code
NYSE:PFE
Year founded
1849
LATEST China Science NEWS

Defects – not jumping tourists – caused deadly Xinjiang bridge collapse: report

Five people died when the Jiangjun Bridge at the Xiata Scenic Area in Yili, Xinjiang, collapsed last year. Photo: Handout

Can Chinese scientists bring Nasa’s ‘space spider’ dream to life?

videocam
Astronauts have been bolting together pre-built space modules since the 1980s. Engineers now seek to fabricate components directly in orbit. Photo: CCTV

China’s dark compute power could be 6,000 times higher than current estimates

videocam
7
AI has emerged as a key battleground in the rivalry between China and the US. Photo: Shutterstock

China names 2 Pakistani astronauts chosen to train for space station mission

videocam
Two Pakistani astronauts have been chosen to train for a Chinese space mission, with one expected to serve as the first foreign astronaut to enter the Tiangong space station. Photo: Xinhua

How China’s AI carbon accounting model points the finger at the US

videocam
China’s new model distributes responsibility by taking into account who actually consumes exported products and the ability of countries’ natural environments to absorb carbon. Photo: Xinhua
MORE China Science NEWS
Pfizer, a leading global research‑based pharmaceutical and biotechnology company, is among the biggest names in the latest cohort. Photo: Reuters
Hong Kong economy

Which global firms are being attracted by Hong Kong’s strategic enterprise scheme?

The South China Morning Post examines 22 firms opening or expanding in the city, with HK$73 billion in investment and 25,000 jobs expected.

Hong Kong economy

Pfizer, Amgen among 22 majors spreading wings in Hong Kong under investment push

China’s private sector

Eli Lilly boosts China footprint with US$3 billion plan to expand supply chain

Medicine

‘Save a fortune’: Trump unveils TrumpRx discount drug site

New platform connects American patients directly to drug makers with promised price cuts on popular medications like Ozempic.

US President Donald Trump at the TrumpRx website launch. Photo: EPA
Biomedicine: Industry Trends

China could approve first AI-designed drug next year, Merck executive says

AI and genetics are creating a ‘seismic shift’ in the pharmaceutical business, experts on Asian Financial Forum panel say.

Biomedicine: Industry Trends

Harbour BioMed stake in US drug developer shows Chinese firms’ growing clout

Latest example of Chinese drug maker acquiring equity in overseas partner shows they are becoming true development partners, analysts say.

Advertisement
Advertisement
Advertisement
Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers signed 157 out-licensing deals with global pharmaceutical firms last year versus 94 a year earlier.

Last year, China approved 76 innovative drugs, including 47 chemical drugs and 23 biologics. Photo: Shutterstock
Made in China 2025

Meow or never: China’s pudgy pets spark race for weight-loss drugs

Fosun and Huadong biotech labs eye feline obesity drugs as owners weigh cuteness against health risks.

United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

Made in China 2025

Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion

Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.

A number of Chinese biotech firms have clinched licensing deals with multinational companies this year. Photo: Shutterstock
Made in China 2025

China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.

The collaboration is “another significant milestone in Fosun Pharma’s strategy of innovation and internationalisation”, according to the company. Photo: Reuters
China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

videocam
Science

Have Chinese chemists cracked the code for cheaper medicine production?

The research team’s straightforward alternative to expensive, complex and dangerous production method hailed as ‘Nobel Prize level’.

videocam
18
US-China relations

Xi-Trump summit opens window of opportunity for US firms at China import expo

More US companies are expected at this year’s China International Import Expo, hoping to secure deals in wake of bilateral summit.

videocam
Preparations are nearly complete for this year’s China International Import Expo in Shanghai. Photo: Xinhua
Hong Kong economy

Letters | How Hong Kong can help Chinese drug makers go global

Readers discuss opportunities from medical innovation, tech standards in Hong Kong, and how to stop people treating corals like inanimate objects.

A view of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone on April 24. Photo: Edmond So
Donald Trump

Trump says Pfizer will cut drug prices for tariff relief

The White House is also planning a direct-to-consumer website called TrumpRx for Americans to buy medication.

Singapore

Singapore’s drug makers may be shielded from US tariffs: Deputy PM Gan

The city state may pursue a ceiling on tariff rates similar to deals that Washington has with other countries, Deputy PM Gan Kim Yong adds.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

Pfizer’s Metsera acquisition to spur Chinese search for new weight drugs

The deal, worth up to US$7.3 billion, will encourage ongoing investment by mainland players but not draw in new rivals, analysts say.

The Pfizer deal is not good news for Chinese firms developing weight-loss drugs with the aim of reducing injections, an analyst says. Photo: Shutterstock
Biomedicine: Companies

China’s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug

The licensing deal for the HRS-1893 innovative drug could fetch as much as US$1.01 billion in milestone payments.

Made in China 2025

China vows stronger biotech support as deals with global drug makers surge

Chinese developers signed one-third of all agreements with global drug firms in the first half of 2025.

Biomedicine: Companies

Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug

Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity investment in 3SBio.

Pfizer agreed to buy a 1.3 per cent equity stake in 3SBio for HK$785 million. Photo: Shutterstock
European Union

EU chief Ursula von der Leyen easily survives parliament no-confidence vote

EU lawmakers dismissed allegations against Ursula von der Leyen regarding private text messaging with Pfizer’s CEO, misuse of funds, and election interference.

European Commission President Ursula von der Leyen survived a no-confidence vote amid far-right tensions and corruption allegations. Photo: EPA
Singapore

Singapore prioritising pharmaceutical supply chains in US tariff talks

Pharmaceutical supply chains account for more than 10 per cent of Singapore’s exports to the US.

CSPC Pharmaceutical

Chinese biotech’s mega drug-licensing deals with multinationals surge

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

Biomedicine: Companies

Chinese biotech firm secures Pfizer deal despite trade tensions

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.

videocam
3SBio was established in 1993 with an initial focus on interferons, a type of protein that helps the immune system. Photo: Handout
European Union

EU’s von der Leyen loses court case over secret Pfizer texts

Wednesday’s ruling is likely to affect how the EU’s executive arm treats text messages in the future.

The New York Times had asked the court to force the disclosure of a message exchange between European Commission President Ursula von der Leyen and Pfizer’s CEO that could show how a costly vaccine deal was struck in 2021. Photo: via AP
Biomedicine: Companies

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

About 52 per cent of Hong Kong respondents said they were willing to get the updated vaccine, compared with 58 per cent in Singapore.

Hong Kong healthcare and hospitals

Elderly Hongkongers can apply for Covid XBB variant vaccine starting Wednesday

Elderly residents can go to community vaccination stations run by private clinics or designated general outpatient clinics under Hospital Authority.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement